Moreover, there were consistently larger proportions of patients covered by treatment than there were patients who had not discontinued treatment (estimated as 1 minus the cumulative incidence of treatment discontinuation) for both study drugs, with these differences increasing over the follow-up period
Here's where most advice falls short
ACS Omega 6:82718278 Wu L-m, Wang Y-x, Zhan Y, Liu A-h, Wang Y-x, Shen H-f, Wang Y-f, Wang L-y, Tao Z-b, Wang Y-q (2021) Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats
GLP-1 receptor signaling differentially modifies the outcomes of sterile vs viral pulmonary inflammation in male mice
They are the leading causes of morbidity and mortality in the modern world [1,2,3,4]